IP Library › Granted Patent US 12,521,530
Granted Patent B2
US 12,521,530 · App. 17/378,446 · Granted Jan 13, 2026

Intravascular devices and methods for delivery of fluids and therapeutic agents into blood vessel walls and intravascular structures

Inventors: Fletcher T. Wilson (San Francisco, CA); Jeffrey M. Elkins (Woodside, CA); Kent D. Dell (Redwood City, CA); Herbert Mendoza (South San Francisco, CA); Michi E. Garrison (Half Moon Bay, CA)
Assignee: INTERVENE, INC.
A61M25/0631A61M25/007A61M25/0075A61M25/09A61M2025/0057A61M2025/09008A61M2202/0478A61M2210/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,521,530
App. No.
17/378,446
Granted
Jan 13, 2026
Kind
B2
Abstract

Intravascular devices and methods for intramural delivery of dissection fluids and infusates are disclosed herein. In some embodiments, the systems include an infusion assembly that can access a vessel wall at a depth within a layer of the vessel wall and advance a tissue manipulation component at approximately the same depth within the vessel wall to create an intramural space within the vessel layer. The infusion assembly can further deliver an infusate that includes a therapeutic drug or other agent into the intramural space.

Claims (43)

1 . A method of intravascularly delivering a therapeutic agent to a target site, the method comprising:

positioning a distal portion of a catheter shaft of an infusion device at a target site within a vein of a patient;

pressing an engagement surface of a housing at the distal portion of the catheter shaft against a venous wall such that the venous wall conforms to the engagement surface to position an exit port at the distal portion of the catheter shaft adjacent to the venous wall at the target site;

actuating an adjustable height component positioned at the distal portion of the catheter shaft to transition a lowermost surface of a needle of the infusion device from a first height to a second height above a support surface at the distal portion of the catheter shaft, wherein, after the actuating, the adjustable height component is positioned to direct the needle into the venous wall with the lowermost surface at the second height;

extending the needle through the exit port to penetrate the venous wall at the target site at the second height to access an intramural space within the venous wall;

moving the needle within the intramural space in a direction generally aligned with a longitudinal axis of the catheter shaft; and

delivering, through the needle, a drug to the intramural space within the venous wall.

2 . The method of claim 1 wherein the needle of the infusion device is slidably positioned within a first lumen of the catheter shaft terminating at the exit port, and wherein the method further comprises:

advancing an imaging component through a second lumen of the catheter shaft to the target site; and

while penetrating the venous wall at the target site, obtaining intravascular images of the venous wall at the target site.

3 . The method of claim 1 wherein pressing the engagement surface against the venous wall comprises expanding a balloon positioned on a side of the catheter shaft facing away from the engagement surface.

4 . The method of claim 1 wherein the target site is a first target site and the intramural space is a first intramural space, and wherein the method further comprises, after delivering the drug to the first target site:

retracting the needle into a lumen fluidly coupled to the exit port;

separating the engagement surface of the housing from the venous wall;

positioning the distal portion of the infusion device at a second target site within the vein;

extending the needle through the exit port to penetrate the venous wall at the second target site to access a second intramural space within the venous wall; and

delivering, through the needle, the drug to the second intramural space within the venous wall.

5 . The method of claim 1 wherein actuating the adjustable height component includes rotating a rotatable guide component at the distal portion of the catheter shaft to position a track of the adjustable height component to transition the lowermost surface of the needle between the first height and the second height.

6 . A method of intravascularly delivering an anti-inflammatory drug to a blood vessel wall, the method comprising:

positioning a distal portion of a catheter shaft of an infusion device at a target site within a vein of a patient;

pressing an engagement surface of a housing at the distal portion of the catheter shaft against a venous wall such that the venous wall conforms to the engagement surface;

extending a fluid delivery tool of the infusion device through an exit port at the distal portion of the catheter shaft to access an intramural space between layers of the venous wall at the target site;

advancing the fluid delivery tool into the intramural space between the layers of the venous wall in a direction generally aligned with a longitudinal axis of the catheter shaft;

delivering, through the fluid delivery tool, the anti-inflammatory drug to the intramural space between the layers of the venous wall to cause the anti-inflammatory drug to be absorbed by the layers of the venous wall at the target site to reduce inflammation adjacent to the target site; and

actuating a height adjustment component positioned at the exit port of the catheter shaft to adjust an axial-most surface of the fluid delivery tool from a first set distance away from the engagement surface to a second set distance away from the engagement surface different from the first set distance.

7 . The method of claim 6 wherein:

advancing the fluid delivery tool within the intramural space includes delivering a hydrodissection fluid, through the fluid delivery tool, to the intramural space to expand the intramural space; and

the method further comprises actuating a valve proximal to the distal portion to switch from a hydrodissection fluid source to an infusion component to supply the anti-inflammatory drug to the fluid delivery tool.

8 . The method of claim 7 wherein the hydrodissection fluid source provides the hydrodissection fluid to the fluid delivery tool at a first fluid pressure and wherein the infusion component provides the anti-inflammatory drug to the fluid delivery tool at a second fluid pressure different from the first fluid pressure.

9 . The method of claim 6 :

the fluid delivery tool comprises a needle and a tube configured to slide over the needle, wherein the tube includes an end port and one or more side holes;

extending the fluid delivery tool through the exit port includes advancing the needle through the exit port to penetrate the venous wall at the target site to access the intramural space;

the method further comprises advancing the tube over the needle after accessing the intramural space such that the needle is positioned proximal to the one or more side holes; and

delivering the anti-inflammatory drug to the intramural space includes delivering the anti-inflammatory drug through the end port and the one or more side holes of the tube to increase an area of the intramural space between the layers of the venous wall absorbing the anti-inflammatory drug.

10 . The method of claim 6 , wherein the target site is a first target site and the intramural space is a first intramural space, and wherein the method further comprises, after delivering the anti-inflammatory drug to the first intramural space:

positioning the distal portion of the catheter shaft of the infusion device at a second target site within the vein;

advancing the fluid delivery tool through the exit port between the layers of the venous wall at the second target site to access a second intramural space within the venous wall; and

delivering, through the fluid delivery tool, the anti-inflammatory drug to the second intramural space between the layers of the venous wall.

11 . The method of claim 6 wherein the fluid delivery tool is advanced into the intramural space between the layers of the venous wall without hydrodissecting the venous wall.

12 . The method of claim 6 , further comprising:

determining a delivery pressure for the anti-inflammatory drug based on characteristics of the venous wall to deliver the anti-inflammatory drug to a predetermined distribution area between the layers of the venous wall, wherein the predetermined distribution area is configured to increase absorption of the anti-inflammatory drug, and

wherein delivering the anti-inflammatory drug to the intramural space between the layers of the venous wall comprises delivering the anti-inflammatory drug at the determined pressure.

13 . The method of claim 6 , further comprising delivering, via an energy source at the distal portion of the catheter shaft, energy to the venous wall after delivering the anti-inflammatory drug to increase absorption of the anti-inflammatory drug.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2021
From: WILSON, FLETCHER T.; ELKINS, JEFFREY M.; DELL, KENT D.; MENDOZA, HERBERT; GARRISON, MICHI E.
To: INTERVENE, INC.
Reel/Frame 057629/0718 →
Continuity (4)
Provisional Application 63167633 · Mar 29, 2021
Provisional Application 63061108 · Aug 4, 2020
Provisional Application 63052900 · Jul 16, 2020
Related Publication 20220016397A1 · Jan 20, 2022
References Cited (181)
US 3704711A · Part · 1972 [cited by applicant]
US 4794931A · Yock · 1989 [cited by examiner]
US 4898574A · Uchiyama et al. · 1990 [cited by applicant]
US 4932962A · Yoon et al. · 1990 [cited by applicant]
US 5112339A · Zelman et al. · 1992 [cited by applicant]
US 5190046A · Shturman et al. · 1993 [cited by applicant]
US 5372601A · Lary · 1994 [cited by applicant]
US 5443443A · Shiber · 1995 [cited by applicant]
US 5464395A · Faxon et al. · 1995 [cited by applicant]
US 5601588A · Tonomura et al. · 1997 [cited by applicant]
US 5606975A · Liang et al. · 1997 [cited by applicant]
US 5695507A · Auth et al. · 1997 [cited by applicant]
US 5738901A · Wang et al. · 1998 [cited by applicant]
US 5795322A · Boudewijn · 1998 [cited by applicant]
US 5810847A · Laufer et al. · 1998 [cited by applicant]
US 5836945A · Perkins · 1998 [cited by applicant]
US 5882340A · Yoon · 1999 [cited by applicant]
US 5989276A · Houser et al. · 1999 [cited by applicant]
US 6190353B1 · Makower · 2001 [cited by applicant]
US 6217554B1 · Green · 2001 [cited by examiner]
US 6302870B1 · Jacobsen et al. · 2001 [cited by applicant]
US 6344027B1 · Goll · 2002 [cited by applicant]
US 6375635B1 · Moutafis et al. · 2002 [cited by applicant]
US 6379319B1 · Garibotto et al. · 2002 [cited by applicant]
US 6458098B1 · Kanesaka · 2002 [cited by applicant]
US 6475226B1 · Belef et al. · 2002 [cited by applicant]
US 6506178B1 · Schubart et al. · 2003 [cited by applicant]
US 6514217B1 · Selmon et al. · 2003 [cited by applicant]
US 6524251B2 · Rabiner et al. · 2003 [cited by applicant]
US 6676665B2 · Foley et al. · 2004 [cited by applicant]
US 6685648B2 · Flaherty et al. · 2004 [cited by applicant]
US 6692466B1 · Chow · 2004 [cited by applicant]
US 6702744B2 · Mandrusov · 2004 [cited by applicant]
US 6726677B1 · Flaherty et al. · 2004 [cited by applicant]
US 6758836B2 · Zawacki · 2004 [cited by applicant]
US 6902576B2 · Drasler et al. · 2005 [cited by applicant]
US 7008411B1 · Mandrusov et al. · 2006 [cited by applicant]
US 7056325B1 · Makower et al. · 2006 [cited by applicant]
US 7150738B2 · Ray · 2006 [cited by applicant]
US 7179249B2 · Steward et al. · 2007 [cited by applicant]
US 7273469B1 · Chan et al. · 2007 [cited by applicant]
US 7357795B2 · Kaji et al. · 2008 [cited by applicant]
US 7462170B2 · Fournie et al. · 2008 [cited by examiner]
US 7517352B2 · Evans · 2009 [cited by applicant]
US 7775968B2 · Viathis · 2010 [cited by applicant]
US 7780592B2 · Tronnes · 2010 [cited by applicant]
US 7918870B2 · Kugler et al. · 2011 [cited by applicant]
US 7927305B2 · Yribarren et al. · 2011 [cited by applicant]
US 7938819B2 · Kugler et al. · 2011 [cited by applicant]
US 7955346B2 · Mauch et al. · 2011 [cited by applicant]
US 8025655B2 · Kugler et al. · 2011 [cited by applicant]
US 8083726B1 · Wang · 2011 [cited by examiner]
US 8083727B2 · Kugler et al. · 2011 [cited by applicant]
US 8100860B2 · Von Oepen et al. · 2012 [cited by applicant]
US 8114123B2 · Brenzel et al. · 2012 [cited by applicant]
US 8177748B1 · Beyerlein · 2012 [cited by applicant]
US 8177802B2 · Mauch et al. · 2012 [cited by applicant]
US 8267947B2 · Pantages et al. · 2012 [cited by applicant]
US 8323261B2 · Kugler · 2012 [cited by applicant]
US 8460316B2 · Wilson et al. · 2013 [cited by applicant]
US 8636712B2 · Kugler et al. · 2014 [cited by applicant]
US 8753366B2 · Makower et al. · 2014 [cited by applicant]
US 9320504B2 · Wilson et al. · 2016 [cited by applicant]
US 9381034B2 · Kawwei · 2016 [cited by applicant]
US 9545289B2 · Wilson et al. · 2017 [cited by applicant]
US 9814538B2 · Kugler et al. · 2017 [cited by applicant]
US 9827005B2 · Wilson et al. · 2017 [cited by applicant]
US 9949752B2 · Wilson et al. · 2018 [cited by applicant]
US 9955990B2 · Wilson et al. · 2018 [cited by applicant]
US 10105157B2 · Wilson et al. · 2018 [cited by applicant]
US 10188419B2 · Wilson et al. · 2019 [cited by applicant]
US 10231613B2 · Wilson et al. · 2019 [cited by applicant]
US 10292807B2 · Wilson et al. · 2019 [cited by applicant]
US 10603018B2 · Wilson et al. · 2020 [cited by applicant]
US 10646247B2 · Wilson et al. · 2020 [cited by applicant]
US 10874413B2 · Wilson et al. · 2020 [cited by applicant]
US 20010041899A1 · Foster · 2001 [cited by applicant]
US 20020029052A1 · Evans et al. · 2002 [cited by applicant]
US 20020072706A1 · Hiblar et al. · 2002 [cited by applicant]
US 20020091362A1 · Maginot · 2002 [cited by applicant]
US 20020103459A1 · Sparks et al. · 2002 [cited by applicant]
US 20020148475A1 · Johnson et al. · 2002 [cited by applicant]
US 20030125663A1 · Coleman et al. · 2003 [cited by applicant]
US 20030144670A1 · Pavcnik et al. · 2003 [cited by applicant]
US 20040158143A1 · Flaherty et al. · 2004 [cited by applicant]
US 20040167558A1 · Igo et al. · 2004 [cited by applicant]
US 20040215339A1 · Drasler et al. · 2004 [cited by applicant]
US 20050014995A1 · Amundson et al. · 2005 [cited by applicant]
US 20050075665A1 · Brenzel et al. · 2005 [cited by applicant]
US 20050165466A1 · Morris et al. · 2005 [cited by applicant]
US 20050273159A1 · Opie · 2005 [cited by applicant]
US 20060094929A1 · Tronnes · 2006 [cited by applicant]
US 20060136045A1 · Flagle et al. · 2006 [cited by applicant]
US 20060156875A1 · McRury et al. · 2006 [cited by applicant]
US 20060178646A1 · Harris et al. · 2006 [cited by applicant]
US 20060184187A1 · Surti · 2006 [cited by applicant]
US 20060235449A1 · Schubart et al. · 2006 [cited by applicant]
US 20060271090A1 · Shaked et al. · 2006 [cited by applicant]
US 20070005093A1 · Cox et al. · 2007 [cited by applicant]
US 20070093780A1 · Kugler · 2007 [cited by applicant]
US 20070093781A1 · Kugler et al. · 2007 [cited by applicant]
US 20070123821A1 · Wang et al. · 2007 [cited by examiner]
US 20070129628A1 · Hirsh · 2007 [cited by applicant]
US 20070208368A1 · Katoh et al. · 2007 [cited by applicant]
US 20080033467A1 · Miyamoto et al. · 2008 [cited by applicant]
US 20080103480A1 · Bosel et al. · 2008 [cited by applicant]
US 20080228171A1 · Kugler et al. · 2008 [cited by applicant]
US 20080228211A1 · Gonon · 2008 [cited by applicant]
US 20080243065A1 · Rottenberg et al. · 2008 [cited by applicant]
US 20080255595A1 · Buchbinder et al. · 2008 [cited by applicant]
US 20090005793A1 · Pantages et al. · 2009 [cited by applicant]
US 20090112059A1 · Nobis · 2009 [cited by applicant]
US 20090149739A9 · Maschke · 2009 [cited by applicant]
US 20090182192A1 · Shiono et al. · 2009 [cited by applicant]
US 20090209910A1 · Kugler et al. · 2009 [cited by applicant]
US 20090254051A1 · Von Oepen et al. · 2009 [cited by applicant]
US 20090270799A1 · Seto et al. · 2009 [cited by applicant]
US 20100076476A1 · To et al. · 2010 [cited by applicant]
US 20100152843A1 · Mauch et al. · 2010 [cited by applicant]
US 20100241147A1 · Maschke · 2010 [cited by applicant]
US 20100256599A1 · Kassab et al. · 2010 [cited by applicant]
US 20110238038A1 · Sefi et al. · 2011 [cited by examiner]
US 20110264127A1 · Mauch et al. · 2011 [cited by applicant]
US 20110264128A1 · Mauch et al. · 2011 [cited by applicant]
US 20120289987A1 · Wilson et al. · 2012 [cited by applicant]
US 20130066346A1 · Pigott et al. · 2013 [cited by applicant]
US 20130103070A1 · Kugler et al. · 2013 [cited by applicant]
US 20130116715A1 · Weber · 2013 [cited by applicant]
US 20130172883A1 · Lopes et al. · 2013 [cited by applicant]
US 20130216114A1 · Courtney et al. · 2013 [cited by applicant]
US 20130317534A1 · Zhou et al. · 2013 [cited by applicant]
US 20140180222A1 · Flaherty et al. · 2014 [cited by examiner]
US 20150057566A1 · Vetter et al. · 2015 [cited by applicant]
US 20150112188A1 · Stigall et al. · 2015 [cited by examiner]
US 20160081656A1 · Abraham · 2016 [cited by applicant]
US 20160184525A1 · Fech et al. · 2016 [cited by examiner]
US 20160374714A1 · Majercak et al. · 2016 [cited by applicant]
US 20180214173A1 · Wilson et al. · 2018 [cited by applicant]
US 20180289441A1 · Wilson et al. · 2018 [cited by applicant]
US 20180333166A1 · Wilson et al. · 2018 [cited by applicant]
US 20180361118A1 · Cully et al. · 2018 [cited by examiner]
US 20190021709A1 · Gallagher et al. · 2019 [cited by examiner]
US 20190201070A1 · Fischell et al. · 2019 [cited by examiner]
US 20190314620A1 · Chang et al. · 2019 [cited by applicant]
US 20200000525A1 · Stigall et al. · 2020 [cited by examiner]
US 20200275975A1 · Chen · 2020 [cited by applicant]
US 20200337726A1 · Wilson · 2020 [cited by examiner]
US 20210060305A1 · Amin et al. · 2021 [cited by examiner]
US 20240156491A1 · Wilson et al. · 2024 [cited by applicant]
US 20240164849A1 · Wilson et al. · 2024 [cited by applicant]
US 20240216006A1 · Wilson et al. · 2024 [cited by applicant]
CA 1281381C · 1991 [cited by applicant]
CA 2678971A1 · 2008 [cited by applicant]
CN 1907243A · 2007 [cited by applicant]
CN 1957861A · 2007 [cited by applicant]
JP 2002514111A · 2002 [cited by applicant]
JP 2003033357A · 2003 [cited by applicant]
JP 2003267160A · 2003 [cited by applicant]
JP 2009165822A · 2009 [cited by applicant]
JP 2009183516A · 2009 [cited by applicant]
RU 2108751C1 · 1998 [cited by applicant]
RU 2160057C2 · 2000 [cited by applicant]
WO 1999000059A1 · 1999 [cited by applicant]
WO 2008063621A2 · 2008 [cited by applicant]
WO 2010074853A1 · 2010 [cited by applicant]
WO 2011106735A1 · 2011 [cited by applicant]
WO 2012030587A1 · 2012 [cited by applicant]
WO 2012145444A2 · 2012 [cited by applicant]
WO 2013119849A1 · 2013 [cited by applicant]
WO 2013159066A1 · 2013 [cited by applicant]
WO 2014110460A1 · 2014 [cited by applicant]
WO 2015077515A1 · 2015 [cited by applicant]
WO 2015148581A1 · 2015 [cited by applicant]
WO 2016025733A1 · 2016 [cited by applicant]
WO 2017210656A1 · 2017 [cited by applicant]
WO 2022016101A2 · 2022 [cited by applicant]
Corcos, I., “A new autologous venous valve by intimal flap: One Cases report.” Note Di Tecnica, Minerva Cardioangiol, 2003, 51, 10 pages. [cited by applicant]
Lugli, M., et al., Neovalve construction in the deep venous incompetence. J. Vasc. Surg., Jan. 2009, 49(1), 156-62. [cited by applicant]
Maleti, O., “Neovalve construction in postthrombotic syndrome,” J. Vaso. Surg., vol. 34, No. 4, 6 pages. [cited by applicant]
International Search Report and Written Opinion dated Jan. 10, 2022; International Application No. PCT/US2021/042049; 25 pages. [cited by applicant]
International Search Report and Written Opinion dated Nov. 23, 2023; International Application No. PCT/US2023/020489; 19 pages. [cited by applicant]